Medicines for All Institute Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Medicines for All Institute's estimated annual revenue is currently $11.7M per year.(i)
  • Medicines for All Institute's estimated revenue per employee is $201,000

Employee Data

  • Medicines for All Institute has 58 Employees.(i)
  • Medicines for All Institute grew their employee count by -9% last year.

Medicines for All Institute's People

NameTitleEmail/Phone
1
Manager (senior scientist 3)Reveal Email/Phone
2
Principal Process ChemistReveal Email/Phone
3
Research ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.9M7925%$210MN/A
#2
$30.2M182N/AN/AN/A
#3
$6.6M336%N/AN/A
#4
$7.8M39-39%N/AN/A
#5
$4.8M244%N/AN/A
#6
$12.5M627%N/AN/A
#7
$22.1M1107%N/AN/A
#8
$11.7M58-9%N/AN/A
#9
$5.8M29-12%N/AN/A
#10
$42.4M211N/AN/AN/A
Add Company

What Is Medicines for All Institute?

The Medicines for All Institute, operating under the auspices of the Virginia Commonwealth University School of Engineering, has developed an innovative model that reduces the cost of manufacturing treatments, such as HIV/AIDS therapies, by accelerating the creation of more efficient ways of synthesizing the active pharmaceutical ingredients in the medications. With funding from the Bill and Melinda Gates Foundation, the Institute’s impact expands well beyond HIV/AIDS, as the process that reduces the cost per kilogram of specific drug targets can be applied to other medicines as well. While meeting an urgent health care need today, the Medicines for All Institute also signals dramatic change in future pharmaceutical manufacturing technologies.

keywords:N/A

N/A

Total Funding

58

Number of Employees

$11.7M

Revenue (est)

-9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$13.1M58-5%N/A
#2
$8.4M58-2%N/A
#3
$11M582%N/A
#4
$17.2M58-2%N/A
#5
$5.2M587%N/A